Clene Is Maintained at Buy by EF Hutton
Clene Price Target Maintained With a $23.00/Share by EF Hutton
Clene Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Clene (CLNN), I-MAB (IMAB)
Maxim Group Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $20
Clene Is Maintained at Buy by EF Hutton
H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31
Buy Rating Justified by Regulatory Progress and Positive ALS Treatment Data for Clene's CNM-Au8
Clene Analyst Ratings
EF Hutton Initiates Clene(CLNN.US) With Buy Rating, Announces Target Price $23
HC Wainwright & Co. Maintains Buy on Clene, Adjusts Price Target To $31 (1-20 Reverse Stock Split)
Clene Analyst Ratings
Buy Rating Justified for Clene Amidst Promising ALS Trial Results and Potential Accelerated FDA Approval
Clene Analyst Ratings
Clene Analyst Ratings
Clene Analyst Ratings
Clene Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK), Biogen (BIIB) and Clene (CLNN)
Clene Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Clene, Maintains $7 Price Target
No Data
No Data